IMMUNOGEN, INC.

IMGN
Real-time Estimate Quote. Real-time Estimate  - 10/19 12:22:01 pm
5.83USD +1.39%
Prev.5.7500
Open5.8400
High5.8400
Low5.5700
Volume993 887
Latest news
3h ago
3h ago
6d ago
6d ago
Chart IMMUNOGEN, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance6,066,416,80
Spread/Res.-4,1%-9,3%-14%
Spread/Supp.32%32%138%
Support4,424,422,44
Financials
Sales 2020 62,9 M - -
Net income 2020 -119 M - -
Net cash 2020 168 M - -
P/E ratio 2020 -8,30x
Yield 2020 -
Capitalization 1 004 M 1 004 M -
EV / Sales 2020 13,3x
EV / Sales 2021 16,7x
Nbr of Employees 75
Free-Float 99,5%
Company
ImmunoGen, Inc. is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. An ADC with the Company's technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-10-30 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 8,11 $
Last Close Price 5,75 $
Spread / Highest target 143%
Spread / Average Target 41,0%
Spread / Lowest Target -30,4%